iPSC reprogramming converts somatic cells into pluripotent stem cells using methods like viral vectors, episomal plasmids, mRNA, or protein delivery. These techniques enable the generation of patient-specific, integration-free iPSCs for disease modeling, drug discovery, and regenerative research. Efficient protocols ensure high-quality, genetically stable lines suitable for translational applications while minimizing genomic alterations and ethical concerns.
